Kumar A, Gangwar R, Ahmad Zargar A, Kumar R, Sharma A. Prevalence of diabetes in india: A review of IDF diabetes atlas 10th edition. Curr Diabetes Rev. 2024;20(1):105–14.

Google Scholar 

Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.

CAS  PubMed  PubMed Central  Google Scholar 

Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X, et al. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol. 2024;14:1265372.

Google Scholar 

Newlin Lew K, Arnold T, Cantelmo C, Jacque F, Posada-Quintero H, Luthra P, et al. Diabetes distal peripheral neuropathy: subtypes and diagnostic and screening technologies. J Diabetes Sci Technol. 2022;16(2):295–320.

CAS  PubMed  PubMed Central  Google Scholar 

Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019;19:1–8.

CAS  Google Scholar 

Kamiya H, Murakawa Y, Zhang W, Sima AA. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes. Diab/Metab Res Rev. 2005;21(5):448–58.

CAS  Google Scholar 

Gandhi M, Fargo E, Prasad-Reddy L, Mahoney KM, Isaacs D. Diabetes: how to manage diabetic peripheral neuropathy. Drugs Context. 2022;11.

Pop-Busui R, Ang L, Boulton AJ, Feldman EL, Marcus RL, Mizokami-Stout K et al. Diagnosis and treatment of painful diabetic peripheral neuropathy. 2022.

Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, et al. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT. Health Technol Assess (Winchester Eng). 2022;26(39):1.

Google Scholar 

Khdour MR. Treatment of diabetic peripheral neuropathy: a review. J Pharm Pharmacol. 2020;72(7):863–72.

CAS  PubMed  Google Scholar 

Kato H, Miyazaki M, Takeuchi M, Tsukuura H, Sugishita M, Noda Y, et al. A retrospective study to identify risk factors for somnolence and Dizziness in patients treated with Pregabalin. J Pharm Health Care Sci. 2015;1:1–5.

Google Scholar 

Brueckle M-S, Thomas ET, Seide SE, Pilz M, Gonzalez-Gonzalez AI, Dinh TS, et al. Amitriptyline’s anticholinergic adverse drug reactions–A systematic multiple-indication review and meta-analysis. PLoS ONE. 2023;18(4):e0284168.

CAS  PubMed  PubMed Central  Google Scholar 

Caillaud M, Aung Myo YP, McKiver BD, Osinska Warncke U, Thompson D, Mann J, et al. Key developments in the potential of Curcumin for the treatment of peripheral neuropathies. Antioxidants. 2020;9(10):950.

CAS  PubMed  PubMed Central  Google Scholar 

Silveira RS, Baldoni AO, Couto RO, Mendonça TS, Domingueti CP. In vivo efficacy of turmeric (Curcuma longa L.) in the treatment of peripheral neuropathy: A systematic review of animal models. An Acad Bras Cienc. 2023;95:e20200447.

CAS  PubMed  Google Scholar 

Zhao Z, Li X, Li Q. Curcumin accelerates the repair of sciatic nerve injury in rats through reducing Schwann cells apoptosis and promoting myelinization. Biomed Pharmacother. 2017;92:1103–10.

CAS  PubMed  Google Scholar 

Asadi S, Gholami MS, Siassi F, Qorbani M, Khamoshian K, Sotoudeh G. Nano Curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial. Complement Ther Med. 2019;43:253–60.

PubMed  Google Scholar 

Committee ADAPP, Committee. ADAPP. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes—2022. Diabetes Care. 2022;45(Supplement1):S17–38.

Google Scholar 

Group TS. Risk factors for diabetic peripheral neuropathy in adolescents and young adults with type 2 diabetes: results from the TODAY study. Diabetes Care. 2022;45(5):1065–72.

Google Scholar 

Ziegler D, Keller J, Maier C, Pannek J. Diabetic neuropathy. Exp Clin Endocrinol Diabetes. 2021;129(S 01):S70–81.

CAS  PubMed  Google Scholar 

Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the international physical activity questionnaire short form (IPAQ-SF): A systematic review. Int J Behav Nutr Phys Activity. 2011;8:1–11.

Google Scholar 

Lv J, Cao L, Zhang R, Bai F, Wei P. A Curcumin derivative J147 ameliorates diabetic peripheral neuropathy in streptozotocin (STZ)-induced DPN rat models through negative regulation AMPK on TRPA1. Acta Cirurgica Brasileira. 2018;33(06):533–41.

PubMed  Google Scholar 

Jia T, Rao J, Zou L, Zhao S, Yi Z, Wu B, et al. Nanoparticle-encapsulated Curcumin inhibits diabetic neuropathic pain involving the P2Y12 receptor in the dorsal root ganglia. Front NeuroSci. 2018;11:755.

PubMed  PubMed Central  Google Scholar 

Joshi RP, Negi G, Kumar A, Pawar YB, Munjal B, Bansal AK et al. SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. Nanomedicine: Nanotechnology, Biology and Medicine. 2013;9(6):776– 85.

Lin Z, Wang S, Cao Y, Lin J, Sun A, Huang W, et al. Bioinformatics and validation reveal the potential target of Curcumin in the treatment of diabetic peripheral neuropathy. Neuropharmacology. 2024;260:110131.

CAS  PubMed  Google Scholar 

Hajimirzaei P, Eyni H, Razmgir M, Abolfazli S, Pirzadeh S, Ahmadi Tabatabaei FS et al. The analgesic effect of Curcumin and nano-curcumin in clinical and preclinical studies: a systematic review and meta-analysis. Naunyn Schmiedebergs Arch Pharmacol. 2024;398(1):393–416.

Jeon Y, Kim C-E, Jung D, Kwak K, Park S, Lim D, et al. Curcumin could prevent the development of chronic neuropathic pain in rats with peripheral nerve injury. Curr Therapeutic Res. 2013;74:1–4.

CAS  Google Scholar 

Di Pierro F, Settembre R. Safety and efficacy of an add-on therapy with Curcumin phytosome and Piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofen. J Pain Res. 2013;6:497–503.

Belcaro G, Hosoi M, Pellegrini L, Appendino G, Ippolito E, Ricci A, et al. A controlled study of a lecithinized delivery system of Curcumin (Meriva®) to alleviate the adverse effects of cancer treatment. Phytother Res. 2014;28(3):444–50.

CAS  PubMed  Google Scholar 

Basu P, Maier C, Basu A. Effects of Curcumin and its different formulations in preclinical and clinical studies of peripheral neuropathic and postoperative pain: a comprehensive review. Int J Mol Sci. 2021;22(9):4666.

CAS  PubMed  PubMed Central  Google Scholar 

Borges GSM, Lages EB, Sicard P, Ferreira LAM, Richard S. Nanomedicine in oncocardiology: contribution and perspectives of preclinical studies. Front Cardiovasc Med. 2021;8:690533.

PubMed  PubMed Central  Google Scholar 

Wang X-S, Zhang Z-R, Zhang M-M, Sun M-X, Wang W-W, Xie C-L. Neuroprotective properties of Curcumin in toxin-base animal models of parkinson’s disease: a systematic experiment literatures review. BMC Complement Altern Med. 2017;17:1–10.

Google Scholar 

Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P. Influence of Piperine on the pharmacokinetics of Curcumin in animals and human volunteers. Planta Med. 1998;64(04):353–6.

CAS  PubMed  Google Scholar 

Rahimi HR, Mohammadpour AH, Dastani M, Jaafari MR, Abnous K, Mobarhan MG, et al. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna J Phytomedicine. 2016;6(5):567.

CAS  Google Scholar 

Mokhtari M, Razzaghi R, Momen-Heravi M. The effects of Curcumin intake on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double‐blind, placebo‐controlled trial. Phytother Res. 2021;35(4):2099–107.

CAS  PubMed  Google Scholar 

Funamoto M, Shimizu K, Sunagawa Y, Katanasaka Y, Miyazaki Y, Kakeya H, et al. Effects of highly absorbable Curcumin in patients with impaired glucose tolerance and non-insulin‐dependent diabetes mellitus. J Diabetes Res. 2019;2019(1):8208237.

PubMed  PubMed Central  Google Scholar 

Adibian M, Hodaei H, Nikpayam O, Sohrab G, Hekmatdoost A, Hedayati M. The effects of Curcumin supplementation on high-sensitivity C‐reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial. Phytother Res. 2019;33(5):1374–83.

CAS  PubMed  Google Scholar 

Vanaie A, Shahidi S, Iraj B, Siadat ZD, Kabirzade M, Shakiba F, et al. Curcumin as a major active component of turmeric attenuates proteinuria in patients with overt diabetic nephropathy. J Res Med Sci. 2019;24(1):77.

CAS  PubMed  PubMed Central  Google Scholar 

Ebrahimzadeh A, Mohseni S, Safargar M, Mohtashamian A, Niknam S, Bakhoda M et al. Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: a systematic review and meta-analysis of randomized clinical trials. Complement Ther Med. 2024;80:103025.

Hadi A, Pourmasoumi M, Ghaedi E, Sahebkar A. The effect of curcumin/turmeric on blood pressure modulation: A systematic review and meta-analysis. Pharmacol Res. 2019;150:104505.

CAS  PubMed  Google Scholar 

wen Tang W, fei Huang F, Haedi AR, Shi QY. The effect of Curcumin supplementation on endothelial function and blood pressure in patients with metabolic disorders: a meta-analysis of meta-analyses. Prostaglandins Other Lipid Mediat. 2024;175:106900.

Mousavi SM, Milajerdi A, Varkaneh HK, Gorjipour MM, Esmaillzadeh A. The effects of Curcumin supplementation on body weight, body mass index and waist circumference: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020;60(1):171–80.

CAS  PubMed  Google Scholar 

Adab Z, Eghtesadi S, Vafa MR, Heydari I, Shojaii A, Haqqani H, et al. Effect of turmeric on glycemic status, lipid profile, hs-CRP, and total antioxidant capacity in hyperlipidemic type 2 diabetes mellitus patients. Phytother Res. 2019;33(4):1173–81.

CAS  PubMed  Google Scholar 

Hodaei H, Adibian M, Nikpayam O, Hedayati M, Sohrab G. The effect of Curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: A randomized, double-blind clinical trial. Diabetol Metab Syndr. 2019;11:1–8.

CAS  Google Scholar 

Ebrahimkhani S, Ghavamzadeh S, Mehdizadeh A. The effects of vitamin D and curcuminoids supplementation on anthropometric measurements and blood pressure in type 2 diabetic patients with coexisting hypovitaminosis D: A double-blind, placebo-controlled randomized clinical trial. Clin Nutr ESPEN. 2020;37:178–86.

PubMed  Google Scholar 

Chuengsamarn S, Rattanamongkolgul S, Phonrat B, Tungtrongchitr R, Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J Nutr Biochem. 2014;25(2):144–50.

CAS